High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
A high-purity inhalable insulin material, used for preparing a pulmonary pharmaceutical product, includes insulin particles having a particle size at the micrometer level and having the following characteristics: (i) the purity of insulin is not less than 96% on the dried basis; (ii) the total amoun...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
20.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A high-purity inhalable insulin material, used for preparing a pulmonary pharmaceutical product, includes insulin particles having a particle size at the micrometer level and having the following characteristics: (i) the purity of insulin is not less than 96% on the dried basis; (ii) the total amount of insulin-related impurities is not more than 2%; (iii) the total amount of solvent impurities, which is not a co-solvent formulation component for a pulmonary product, is not more than 0.03%; and (iv) the total amount of non-solvent impurities is not more than 0.3%. Up to 99% by volume of the insulin particles in the inhalable insulin have a particle size of less than 5 μm, based on the total volume of the insulin particles. A high-efficiency method prepares high-purity inhalable insulin material. The yield rate for the high-efficiency method is 75 to 85% or more. |
---|---|
AbstractList | A high-purity inhalable insulin material, used for preparing a pulmonary pharmaceutical product, includes insulin particles having a particle size at the micrometer level and having the following characteristics: (i) the purity of insulin is not less than 96% on the dried basis; (ii) the total amount of insulin-related impurities is not more than 2%; (iii) the total amount of solvent impurities, which is not a co-solvent formulation component for a pulmonary product, is not more than 0.03%; and (iv) the total amount of non-solvent impurities is not more than 0.3%. Up to 99% by volume of the insulin particles in the inhalable insulin have a particle size of less than 5 μm, based on the total volume of the insulin particles. A high-efficiency method prepares high-purity inhalable insulin material. The yield rate for the high-efficiency method is 75 to 85% or more. |
Author | Ding, Jeffrey Zhang, Jack Yongfeng Luo, Mary Ziping Bo, Aili |
Author_xml | – fullname: Zhang, Jack Yongfeng – fullname: Luo, Mary Ziping – fullname: Ding, Jeffrey – fullname: Bo, Aili |
BookMark | eNqNjb0KwjAUhTPo4N87xN2CtaUPoCjd1blc401zIb0JTYL07a3FwdHpHD7Oz1LM2DEuxKum1mQ-9RQHSWzAwsOi9NBHUhaDdHrEIVliCfz88WBdmzDsJmw-K6g1KUJWg-wwGvec2h1w0qDieMGtjAZlgA7XYq7BBtx8dSW2l_PtVGfoXYPBg0LG2NyveV6WVVHtj4fin8wb_PFH8w |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US11446360B2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US11446360B23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:50:13 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US11446360B23 |
Notes | Application Number: US201916553681 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220920&DB=EPODOC&CC=US&NR=11446360B2 |
ParticipantIDs | epo_espacenet_US11446360B2 |
PublicationCentury | 2000 |
PublicationDate | 20220920 |
PublicationDateYYYYMMDD | 2022-09-20 |
PublicationDate_xml | – month: 09 year: 2022 text: 20220920 day: 20 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | AMPHASTAR PHARMACEUTCALS, INC Amphastar Pharmaceuticals, Inc |
RelatedCompanies_xml | – name: Amphastar Pharmaceuticals, Inc – name: AMPHASTAR PHARMACEUTCALS, INC |
Score | 3.430263 |
Snippet | A high-purity inhalable insulin material, used for preparing a pulmonary pharmaceutical product, includes insulin particles having a particle size at the... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220920&DB=EPODOC&locale=&CC=US&NR=11446360B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEB5KFfWmVdH6IILsyWC67x4WobstRegD20pvZZtNsGKzi7ulf98k3dpe9BYSEsjAzOTxfd8APFoNnlDOCJapjmHbMmPs87iBPZ7YzFE1j4giCvf6bndiv06daQU-t1wYrRO61uKI0qOo9PdCx-ts94gVaWxl_jxfyK70pTMOIqO8HZsmaZrEiFpBeziIBqERhsFkZPTfgoa691guaclwfaCO0Upnv_3eUqyUbD-ldE7hcChXE8UZVJiowXG4rbxWg6Ne-eEtm6Xv5eewVpAMnOlqc2ghPuIvxXpC2RbahlKOSmQ5ikWy1968z-RPulvpE2OmhSMU6xJtSkjr2ctYrBTRQTMXkTwZojxesgt46LTHYRfLHcx-zTWbjHabtS6hKlLBrgBZvk25ZzueR6ntMtr0eWL5c-owN_EJM6-h_vc69f8Gb-BEmV6hKExyC9Xie8XuZKou5vfaxj-uG5uS |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bT8IwFD4haMQ3RY3irSZmTy6W3XlYTNggqNwiYHgjo2sjRsriRvj7tmUIL_rWnKZN2ub09PJ93wG4N6ssJoxiXYQ6qlumEekei6q6y2KL2jLnEZZE4U7XaY2sl7E9LsDnhgujdEJXShxReBQR_p6p_TrZPmKFCluZPk5nwrR4ag79UMtvx4aBawbWwrrf6PfCXqAFgT8aaN03vyrvPaaD62K73nOlOq88Or3XJSsl2Q0pzSPY74veeHYMBcrLUAo2mdfKcNDJP7xFMfe99ARWEpKhJyrbHJrxj-hLsp5QsoG2oQVDObIcRTzeKa_fZ9IHZZb6xDpVwhGSdYnWKaRV63nEl5LooJiLSJwMURrN6SncNRvDoKWLEUx-p2syGmwHa55BkS84PQdkehZhrmW7LiGWQ0nNY7HpTYlNndjD1LiAyt_9VP6rvIVSa9hpT9rP3ddLOJTLIBEVBr6CYva9pNcibGfTGzXfPx6gnn8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=High-purity+inhalable+particles+of+insulin+and+insulin+analogues%2C+and+high-efficiency+methods+of+manufacturing+the+same&rft.inventor=Zhang%2C+Jack+Yongfeng&rft.inventor=Luo%2C+Mary+Ziping&rft.inventor=Ding%2C+Jeffrey&rft.inventor=Bo%2C+Aili&rft.date=2022-09-20&rft.externalDBID=B2&rft.externalDocID=US11446360B2 |